Fulgent Genetics (FLGT) Depreciation and Depletion (2017 - 2026)

Fulgent Genetics (FLGT) has 10 years of Depreciation and Depletion data on file, last reported at $3.9 million in Q1 2026.

• Quarterly Depreciation and Depletion rose 2.63% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.7 million (up 0.64% YoY) and the FY2025 annual result came in at $15.7 million, down 4.27% from the prior year.
• Depreciation and Depletion retreated to $3.9 million in Q1 2026 per FLGT's latest filing, from $4.0 million in the prior quarter.
• The five-year high for Depreciation and Depletion was $7.6 million in Q3 2022, with the low at $3.7 million in Q1 2022.
• Average Depreciation and Depletion over 5 years is $4.6 million, with a median of $4.0 million recorded in 2024.
• Year-over-year, Depreciation and Depletion surged 204.0% in 2022 and tumbled 43.42% in 2023.
• Fulgent Genetics' Depreciation and Depletion stood at $7.6 million in 2022, then plunged by 42.11% to $4.4 million in 2023, then declined by 9.09% to $4.0 million in 2024, then increased by 0.0% to $4.0 million in 2025, then decreased by 2.5% to $3.9 million in 2026.
• Business Quant data shows FLGT's Depreciation and Depletion at $3.9 million in Q1 2026, $4.0 million in Q4 2025, and $3.9 million in Q3 2025.